WFS1 protein expression correlates with clinical progression of optic atrophy in patients with Wolfram syndrome. (2022)
Attributed to:
Development of a novel repurposed drug treatment for the neurodegeneration and diabetes in Wolfram syndrome
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.17863/cam.70246
Publication URI: https://www.repository.cam.ac.uk/handle/1810/322790
Type: Journal Article/Review